Related Experiment Video
Updated: Jun 16, 2026

A Comprehensive Protocol for Manual Segmentation of the Medial Temporal Lobe Structures
Published on: July 2, 2014
Volume loss of the medial temporal lobe structures in subjective memory impairment
Nadine Striepens1, Lukas Scheef, Andrea Wind
1Department of Psychiatry, University of Bonn, Germany. nadine.striepens@web.de
Background/Aims:
Subjective memory impairment (SMI) has been suggested as a manifestation of Alzheimer's Disease (AD) preceding mild cognitive impairment (MCI). In this study, we determined the volumes of the hippocampus, the entorhinal cortex (EC) and the amygdala to provide biological evidence for AD in SMI.
Methods:
Regional volumetric measures were manually traced on 3-Tesla MRI scans.
Results:
Total brain volume did not differ between the groups. Individuals with SMI had reduced volumes of the hippocampus bilaterally (right p = 0.001; left p < 0.001), the bilateral EC (right p = 0.031, left p = 0.006) and the right amygdala (p = 0.01) compared to the control group.
Conclusion:
Volume reduction of bilateral hippocampus, bilateral EC and right amygdala supports the concept of SMI as a very early manifestation of AD prior to MCI. SMI may indicate awareness of a degenerative process that can still be functionally compensated.
Insights
Subjective memory impairment (SMI) may signal early Alzheimer's Disease (AD). Brain scans show reduced hippocampus, entorhinal cortex, and amygdala volumes in individuals with SMI, suggesting a preclinical AD stage.
Area of Science:
- Neuroimaging
- Neurology
- Alzheimer's Disease Research
Background:
- Subjective memory impairment (SMI) is a potential early indicator of Alzheimer's Disease (AD).
- SMI may precede mild cognitive impairment (MCI) in the AD progression.
- Investigating neuroanatomical changes in SMI is crucial for early AD detection.
Purpose of the Study:
- To provide biological evidence for Alzheimer's Disease (AD) in individuals experiencing Subjective Memory Impairment (SMI).
- To determine if specific brain region volumes are reduced in SMI patients compared to controls.
- To assess the potential of SMI as a preclinical marker for AD.
Main Methods:
- Utilized 3-Tesla Magnetic Resonance Imaging (MRI) scans.
- Manually traced regional volumetric measures of key brain structures.
- Compared brain volumes between individuals with SMI and a healthy control group.
Main Results:
- No significant difference in total brain volume was observed between groups.
- Individuals with SMI exhibited reduced bilateral hippocampus volumes.
- Significant reductions were found in bilateral entorhinal cortex and right amygdala volumes in the SMI group.
Conclusions:
- Reduced volumes in the hippocampus, entorhinal cortex, and amygdala support SMI as an early manifestation of AD.
- SMI may reflect an early neurodegenerative process that is still functionally compensated.
- These findings highlight the potential of volumetric MRI for identifying preclinical AD.
More Related Videos
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Related Concept Videos
Role of Hippocampus in Memory
Dementia l: Introduction
Amnesia
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
Higher Mental Functions of Brain: Learning and Memory
Alzheimer Disease ll: Pathophysiology
Dissociative Amnesia